Partial growth hormone deficiency is associated with an adverse cardiovascular risk profile and increased carotid intima-medial thickness

Clinical Endocrinology

Volumn 73, Issue 4, 2010, Pages 508-515

  Murray, Robert D ^a,b   Wieringa, Gilbert ^c   Lawrance, Jeremy A ^c   Adams, Judith E ^d   Shalet, Stephen M ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^c CHRISTIE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN; GROWTH HORMONE; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR 1; SOMATOMEDIN C; TRIACYLGLYCEROL;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BODY FAT; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; GROWTH HORMONE DEFICIENCY; HORMONAL REGULATION; HUMAN; LIPID BLOOD LEVEL; PREVALENCE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST HIP RATIO;

ADULT; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LIPIDS; MALE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RISK FACTORS; TUNICA INTIMA; TUNICA MEDIA; WAIST-HIP RATIO;

EID: 77957083477     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2009.03754.x     Document Type: Article

References (49)

1. Rosen, T. Bengtsson, B.A. (1990) Premature mortality due to cardiovascular disease in hypopituitarism. Lancet, 336 : 285 288.
2. Tomlinson, J.W., Holden, N., Hills, R.K. et al. (2001) Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet, 357 : 425 431.
3. Bulow, B., Hagmar, L., Mikoczy, Z. et al. (1997) Increased cerebrovascular mortality in patients with hypopituitarism. Clinical Endocrinology, 46 : 75 81.
4. Cuneo, R.C., Salomon, F., Watts, G.F. et al. (1993) Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency. Metabolism: Clinical and Experimental, 42 : 1519 1523.
5. Rosen, T., Eden, S., Larson, G. et al. (1993) Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinologica, 129 : 195 200. (Pubitemid 23295679)
6. al-Shoumer, K.A., Cox, K.H., Hughes, C.L. et al. (1997) Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy. Journal of Clinical Endocrinology and Metabolism, 82 : 2653 2659.
7. Johansson, J.O., Landin, K., Tengborn, L. et al. (1994) High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults. Arteriosclerosis and Thrombosis, 14 : 434 437.
8. Johansson, J.O., Fowelin, J., Landin, K. et al. (1995) Growth hormone-deficient adults are insulin-resistant. Metabolism: Clinical and Experimental, 44 : 1126 1129.
9. Hew, F.L., Koschmann, M., Christopher, M. et al. (1996) Insulin resistance in growth hormone-deficient adults: defects in glucose utilization and glycogen synthase activity. Journal of Clinical Endocrinology and Metabolism, 81 : 555 564.
10. Evans, L.M., Davies, J.S., Goodfellow, J. et al. (1999) Endothelial dysfunction in hypopituitary adults with growth hormone deficiency. Clinical Endocrinology, 50 : 457 464.
11. Markussis, V., Beshyah, S.A., Fisher, C. et al. (1992) Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet, 340 : 1188 1192.
12. Cittadini, A., Cuocolo, A., Merola, B. et al. (1994) Impaired cardiac performance in GH-deficient adults and its improvement after GH replacement. American Journal of Physiology, 267 : E219 E225.
13. Longobardi, S., Cuocolo, A., Merola, B. et al. (1998) Left ventricular function in young adults with childhood and adulthood onset growth hormone deficiency. Clinical Endocrinology, 48 : 137 143.
14. Rahim, A., Toogood, A.A. Shalet, S.M. (1996) The assessment of growth hormone status in normal young adult males using a variety of provocative agents. Clinical Endocrinology, 45 : 557 562.
15. Hoeck, H.C., Jakobsen, P.E., Vestergaard, P. et al. (1999) Differences in reproducibility and peak growth hormone responses to repeated testing with various stimulators in healthy adults. Growth Hormone & IGF Research, 9 : 18 24.
16. Murray, R.D., Bidlingmaier, M., Strasburger, C.J. et al. (2007) The diagnosis of partial growth hormone deficiency in adults with a putative insult to the hypothalamo-pituitary axis. Journal of Clinical Endocrinology and Metabolism, 92 : 1705 1709.
17. Murray, R.D., Adams, J.E. Shalet, S.M. (2004) Adults with partial growth hormone deficiency have an adverse body composition. Journal of Clinical Endocrinology and Metabolism, 89 : 1586 1591.
18. Murray, R.D., Adams, J.E. Shalet, S.M. (2006) A densitometric and morphometric analysis of the skeleton in adults with varying degrees of growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 91 : 432 438.
19. Murray, R.D. Shalet, S.M. (2005) Insulin sensitivity is impaired in adults with varying degrees of GH deficiency. Clinical Endocrinology, 62 : 182 188.
20. Murray, R.D. (2005) The phenotype of adults with partial growth hormone deficiency. Hormone Research, 64 (Suppl. 2 12 17.
21. Colao, A., Cerbone, G., Pivonello, R. et al. (1999) The growth hormone (GH) response to the arginine plus GH-releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency. Journal of Clinical Endocrinology and Metabolism, 84 : 1277 1282.
22. Colao, A., Di Somma, C., Cuocolo, A. et al. (2004) The severity of growth hormone deficiency correlates with the severity of cardiac impairment in 100 adult patients with hypopituitarism: an observational, case-control study. Journal of Clinical Endocrinology and Metabolism, 89 : 5998 6004.
23. Colao, A., Di Somma, C., Pivonello, R. et al. (1999) Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism. Journal of Clinical Endocrinology and Metabolism, 84 : 1919 1924.
24. Growth-Hormone-Research-Society (1998) Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. Journal of Clinical Endocrinology and Metabolism, 83 : 379 381.
25. Toogood, A.A., Beardwell, C.G. Shalet, S.M. (1994) The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism. Clinical Endocrinology, 41 : 511 516.
26. Darzy, K.H., Aimaretti, G., Wieringa, G. et al. (2003) The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval. Journal of Clinical Endocrinology and Metabolism, 88 : 95 102.
27. Aimaretti, G., Corneli, G., Razzore, P. et al. (1998) Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults. Journal of Clinical Endocrinology and Metabolism, 83 : 1615 1618.
28. Bonora, E., Moghetti, P., Zancanaro, C. et al. (1989) Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. Journal of Clinical Endocrinology and Metabolism, 68 : 374 378.
29. Akinmokun, A., Selby, P.L., Ramaiya, K. et al. (1992) The short insulin tolerance test for determination of insulin sensitivity: a comparison with the euglycaemic clamp. Diabetic Medicine, 9 : 432 437.
30. Murray, R.D., Wieringa, G.E., Lissett, C.A. et al. (2002) Low-dose GH replacement improves the adverse lipid profile associated with the adult GH deficiency syndrome. Clinical Endocrinology, 56 : 525 532.
31. Bates, A.S., Van't Hoff, W., Jones, P.J. et al. (1996) The effect of hypopituitarism on life expectancy. Journal of Clinical Endocrinology and Metabolism, 81 : 1169 1172.
32. Ridker, P.M., Hennekens, C.H., Buring, J.E. et al. (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. New England Journal of Medicine, 342 : 836 843.
33. Ariyo, A.A., Thach, C. Tracy, R. (2003) Lp(a) lipoprotein, vascular disease, and mortality in the elderly. New England Journal of Medicine, 349 : 2108 2115.
34. Danesh, J., Lewington, S., Thompson, S.G. et al. (2005) Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA, 294 : 1799 1809.
35. Scarabin, P.Y., Aillaud, M.F., Amouyel, P. et al. (1998) Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction - the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction. Thrombosis and Haemostasis, 80 : 749 756.
36. Kvasnicka, J., Marek, J., Kvasnicka, T. et al. (2000) Increase of adhesion molecules, fibrinogen, type-1 plasminogen activator inhibitor and orosomucoid in growth hormone (GH) deficient adults and their modulation by recombinant human GH replacement. Clinical Endocrinology, 52 : 543 548.
37. Colao, A., di Somma, C., Pivonello, R. et al. (2002) The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study. Journal of Clinical Endocrinology and Metabolism, 87 : 1088 1093.
38. Smith, J.C., Lane, H.A., Lewis, J. et al. (2003) Endothelial function and coagulant factors in growth hormone-treated hypopituitary adults receiving desmopressin. Journal of Clinical Endocrinology and Metabolism, 88 : 2152 2156.
39. Lanes, R., Gunczler, P., Lopez, E. et al. (2001) Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents. Journal of Clinical Endocrinology and Metabolism, 86 : 1061 1065.
40. Sesmilo, G., Miller, K.K., Hayden, D. et al. (2001) Inflammatory cardiovascular risk markers in women with hypopituitarism. Journal of Clinical Endocrinology and Metabolism, 86 : 5774 5781.
41. Gomez, J.M., Sahun, M., Vila, R. et al. (2006) Peripheral fibrinolytic markers, soluble adhesion molecules, inflammatory cytokines and endothelial function in hypopituitary adults with growth hormone deficiency. Clinical Endocrinology, 64 : 632 639.
42. Leonsson, M., Hulthe, J., Johannsson, G. et al. (2003) Increased interleukin-6 levels in pituitary-deficient patients are independently related to their carotid intima-media thickness. Clinical Endocrinology, 59 : 242 250.
43. Capaldo, B., Patti, L., Oliviero, U. et al. (1997) Increased arterial intima-media thickness in childhood-onset growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 82 : 1378 1381.
44. Abdu, T.A., Neary, R., Elhadd, T.A. et al. (2001) Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities. Clinical Endocrinology, 55 : 209 216. (Pubitemid 32868585)
45. Pfeifer, M., Verhovec, R., Zizek, B. et al. (1999) Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults. Journal of Clinical Endocrinology and Metabolism, 84 : 453 457.
46. Leonsson, M., Hulthe, J., Oscarsson, J. et al. (2002) Intima-media thickness in cardiovascularly asymptomatic hypopituitary adults with growth hormone deficiency: relation to body mass index, gender, and other cardiovascular risk factors. Clinical Endocrinology, 57 : 751 759.
47. Colao, A., Di Somma, C., Spiezia, S. et al. (2006) The natural history of partial growth hormone deficiency in adults: a prospective study on the cardiovascular risk and atherosclerosis. Journal of Clinical Endocrinology and Metabolism, 91 : 2191 2200.
48. So, N.M., Lam, W.W., Chook, P. et al. (2002) Carotid intima-media thickness in patients with head and neck irradiation for the treatment of nasopharyngeal carcinoma. Clinical Radiology, 57 : 600 603.
49. King, L.J., Hasnain, S.N., Webb, J.A. et al. (1999) Asymptomatic carotid arterial disease in young patients following neck radiation therapy for Hodgkin lymphoma. Radiology, 213 : 167 172.